Register entry
- Registered sites
- 0
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
33 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.
| Dosage form | NDCs |
|---|---|
| capsule | 2 |
| gel | 1 |
| Route | NDCs |
|---|---|
| oral | 2 |
| topical | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| amryt pharmaceuticals dac | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| FILSUVEZ | birch triterpenes | gel, topical | 76431-310NDA |
| Juxtapid | lomitapide mesylate | capsule, oral | 76431-110NDA |
| Juxtapid | lomitapide mesylate | capsule, oral | 76431-120NDA |
Compare
Other companies listing lomitapide mesylate
- Chiesi USA, Inc.1 site · 25 NDC
Enquiry
Common questions
- Is Amryt Pharmaceuticals DAC FDA approved?
- Amryt Pharmaceuticals DAC holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Amryt Pharmaceuticals DAC make?
- 3 products are listed under Amryt Pharmaceuticals DAC in the openFDA NDC Directory, most often as capsule; gel. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.